Omeros reported $145.39M in Assets for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acelrx Pharmaceuticals ACRX:US $ 79.59M 7.76M
Adamas Pharmaceuticals ADMS:US 150.64M 18.6M
Adma Biologics ADMA:US $ 232.81M 2.85M
Aerie Pharmaceuticals AERI:US $ 355.53M 7.2M
Alexion Pharmaceuticals ALXN:US $ 18650.2M 547.2M
Alnylam Pharmaceuticals ALNY:US $ 3509.43M 254.16M
Biomarin Pharmaceutical BMRN:US $ 5898.5M 93.44M
Cytokinetics CYTK:US $ 564.3M 12.76M
Dynavax Technologies DVAX:US $ 647.91M 157.79M
Gilead Sciences GILD:US $ 67984M 492M
Heron Therapeutics HRTX:US $ 404.25M 93.32M
Insmed INSM:US $ 1.23B 537.39M
Intercept Pharmaceuticals ICPT:US $ 523.22M 3.11M
Knight Therapeutics Inc GUD:CN C$ 1.04B 42.85M
Macrogenics MGNX:US $ 425.91M 9.53M
Mirati Therapeutics MRTX:US $ 1355.7M 25.14M
Omeros OMER:US $ 145.39M 16.05M
Pacira Pharmaceuticals PCRX:US $ 1325.83M 38.28M
Regulus Therapeutics RGLS:US $ 49.52M 9.68M
Rockwell Medical RMTI:US $ 63.68M 5.76M
Sangamo Biosciences SGMO:US $ 835.36M 41.73M
Sarepta Therapeutics SRPT:US $ 2759.07M 6.16M
United Therapeutics UTHR:US $ 4844.9M 203.9M
Vertex Pharmaceuticals VRTX:US $ 12221.69M 106.63M
Vital Therapies VTL:US $ 136.06M 18.67M
Xoma XOMA:US $ 135.75M 15.86M